Antigenicity of HM10411 in Guinea Pigs |
Woo Suk Koh
(한국화학연구원 부설 안전성평가 연구소)
Jong-Choon Kim (한국화학연구원 부설 안전성평가 연구소) Shin Woo Cha (한국화학연구원 부설 안전성평가 연구소) Young Min Kim (한미약품(주) 중앙연구소) Sung Youb Jung (한미약품(주) 중앙연구소) Se Chang Kwon (한미약품(주) 중앙연구소) Gwan Sun Lee (한미약품(주) 중앙연구소) |
1 | 백남기, 강경구, 이순복, 김원배, 양중의(1994). Guinea pig 및 mouse에 있어서 인형 과립구 콜로니 자극인자 DA-3030의 항원성. 응용약물학회지 2, 292-297 |
2 | Donald M. (1985). The granulocyte-macrophage colony-stim-ulating factors. Science, 229, 16-22 DOI |
3 | Haniu M., Horan T., Arakawa T., Le J., Katta V., Hara S., Rochde M. F. (1996). Disulfide structure and N-glycosyla-don sites of an extracellular domain of granulocyte-colony stimulating factor receptor. Biochemistry, 35(40), 13040-13046 DOI ScienceOn |
4 | Kang K-S, Che J-H, Kim K-B, Lee J-H, Cho S-D, Cho J-H, Park J-S, Ahn N-S, Yang S-R, Jung J-W, Lee Y-S, Kwon S-C, Kim Y-M, Jung S-Y, Bae S-M and Lee G-S. (2001)Therapeutic effect of HM10411 on neutropema caused by anticancer agents in mice. J. Toxicol. Pub. Health, 17, 151-157 |
5 | Karol M. H. and Graham C. (1997). Antibody-mediated hypersensitivity. in [Comprehensive toxicology; Ed. Lawrence D.A,, vol. 5 (Toxicology of the immune system)], Perga-mon Press, New York, pp. 305-322 |
6 | Lu H. S., Clogston C. L., Narhi L. O., Merewether L. A., Pearl W. R. and Boor T. C. (1992). Folding and oxidation of recombinant human granulocyte-colony stimulating fac-tor produced in Escherichia coli. Characterization of the disulfide-reduced intermediates and cystem-serine analogs. J. Biol. Chem., 267(13), 8770-8777 |
7 | Lyman G. H., Kuderer N. M. and Djulbegovic B. (2002), Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a metaanaly-sis. Am. J. Med., 112(5), 406-411 DOI ScienceOn |
8 | Bodey G. (1986). Infection in cancer patients: A continuing association. Am. J. Med. (Suppl 1A), 81, 11-26 |
9 | Bokemeyer C., Honecker F., Wedding U., Spaeth-Schwalbe E., Lipp H. P., Kolb G. (2002). Use of hematopoietic growth factors in elderly patients receiving cytotoxic che-motherapy. Onkologie, 25(1), 32-39 DOI ScienceOn |
10 | Mota I. and Wong D. (1969). Homologous and heterologous passive cutaneous anaphylatic activity of mouse antisera during the course of immunization. Life Sci., 8, 813-820 DOI ScienceOn |
11 | Nagata S. (1994). Granulocyte colony stimulating factor and its receptor. In The cytokine handbook (Thompson A. Ed), pp. 371-385. Academic Press, London |
12 | Ottmann O. G., Welte K., Souza L. M. and Moore M. A. (1987). Proliferative effects of a recombinant human granu locyte colony-stimulating factor (rG-CSF) on highly eniich ed hematopoietic progenitor cells. Hematol Bluttransfus, 31, 244-247 |
13 | Pizzo P. A. (1984). Granulocytopema and cancer chemother apy: past problems, current solutions, future challenges. Cancer, 54, 2649-2661 DOI ScienceOn |